logo-loader

Proactive events

Proactive One2One Investor Forum

20 May 2021 | London

Virtual

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

1614865492_faron
Faron Pharmaceuticals Limited

Faron Pharmaceuticals Limited is a clinical-stage biopharmaceutical company based in Finland and the United States, with a focus on developing bexmarilimab, a first-in-class, humanized antibody that binds the Clever-1 target on myeloid cells and...

1632998027_bs
Benchmark Holdings PLC

Benchmark Holdings PLC is a market leading aquaculture biotechnology company. The company's mission is to drive sustainability in aquaculture by delivering mission critical products and solutions that improve farming...

1642129506_angle-l
ANGLE PLC

ANGLE PLC is a world-leading liquid biopsy company with sample-to-answer solutions. The company's proven patent-protected circulating tumour cell (CTC) harvesting technology is known as the Parsortix® system. Parsortix® is...

sss
Allergy Therapeutics PLC

Allergy Therapeutics PLC is an international commercial biotechnology company focused on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. It sells...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.